Literature DB >> 1362408

Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A.

A Miya1, M Yamamoto, H Morimoto, N Tanaka, E Shin, K Karakawa, K Toyoshima, Y Ishizaka, T Mori, S Takai.   

Abstract

We studied the expression of the ret proto-oncogene (proto-ret) in human medullary thyroid carcinomas (MTCs) and pheochromocytomas of multiple endocrine neoplasia type 2A (MEN 2A) by Northern blot analysis. Expression of the normal-sized transcripts was detected in all 12 MTCs and in 6 of 8 pheochromocytomas. In situ localization of proto-ret mRNA revealed that the signal was confined to the cytoplasm of MTC cells. By Southern blot analysis neither amplification nor gross genetic changes of proto-ret were found in the tumors. Although no transcripts were detected in the normal portion of the thyroid from one MEN 2A patient, faint signals were detected in normal adrenal glands by Northern blot analysis, probably due to minor populations of C-cells and chromaffin cells in specimens from which MTC and pheochromocytoma might later develop. Proto-ret may play an important role in differentiation of a specific cell lineage from neuroectoderm, and it may be involved in development of MEN 2A tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362408

Source DB:  PubMed          Journal:  Henry Ford Hosp Med J        ISSN: 0018-0416


  5 in total

1.  No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma.

Authors:  R M Hofstra; N C Cheng; C Hansen; R P Stulp; T Stelwagen; N Clausen; N Tommerup; H Caron; A Westerveld; R Versteeg; C H Buys
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

2.  Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing.

Authors:  P Komminoth; E Kunz; O Hiort; S Schröder; X Matias-Guiu; G Christiansen; J Roth; P U Heitz
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

3.  Molecular Diagnosis of Multiple Endocrine Neoplasia (MEN) in Paraffin-Embedded Specimens.

Authors:  Paul Komminoth; Seraina Muletta-Feurer; Parvin Saremaslani; Eva K. Kunz; Xavier Matias-Guiu; Olaf Hiort; Soren Schroder; Walter K. F. Seelentag; Jurgen Roth; Philipp U. Heitz
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

4.  Presymptomatic genetic screening in families with multiple endocrine neoplasia type 2.

Authors:  A Frilling; W Höppner; C Eng; L Mulligan; F Raue; C E Broelsch
Journal:  J Mol Med (Berl)       Date:  1995-05       Impact factor: 4.599

5.  Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.

Authors:  K M Carlson; S Dou; D Chi; N Scavarda; K Toshima; C E Jackson; S A Wells; P J Goodfellow; H Donis-Keller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.